<DOC>
	<DOCNO>NCT00415363</DOCNO>
	<brief_summary>This study multinational study compare enzastaurin versus placebo treatment patient brain metastasis lung cancer . Approximately 108 patient randomly assign receive either enzastaurin placebo complete whole brain radiotherapy .</brief_summary>
	<brief_title>Study Enzastaurin Versus Placebo Treatment Patients With Brain Metastases Lung Cancer , After Whole Brain Radiation Therapy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>Having radiologically proven brain metastasis lung cancer Having receive whole brain radiotherapy either 30 gray 2 week 20 gray one week . Treatment enzastaurin must start within 14 day last fraction whole brain radiotherapy No previous radiotherapy brain except radiosurgery one occasion Adequate organ function measure appropriate laboratory test . Age 18 year old . Inability swallow tablet show condition could interfere oral medication intake ( e.g . vomiting , partial bowel obstruction ) . Inability discontinue use certain antiepileptic drug , carbamazepine , phenobarbital phenytoin . Concurrent administration warfarin Hemophilia Having systemic anticancer treatment within last 2 week prior enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>